Oct 2026
Longitudinal SARS-CoV-2 mRNA vaccine immunogenicity in inflammatory bowel disease in relation to anti-TNF therapy and age: a prospective cohort study.
BACKGROUND Patients with inflammatory bowel disease (IBD) on immunomodulatory therapy may respond less well to vaccination. We followed humoral and cellular responses to SARS-CoV-2 vaccination over 12 months. METHODS In this single-centre, prospective cohort study, adults with IBD received mRNA vaccine under the Aust...
Wolfram Mayr, Astrid I. Knell, A. Boehm et al.
· Vaccine · 0 citations